Categories: Asia Pacific Focus

Covid-19 Under Trial Vaccines Out In Chinese Black Market

Last updated on November 28th, 2020 at 06:07 am

Chinese Black Market: There is a black market around Covid-19 vaccines is already doing its magic in China, even before the efficacy of any of the trail vaccines could be proven. People are desperate and are looking for ways to get a hold of even vaccines in trail through employees at various laboratories. 

China apparently has allowed local developed vaccine shots since the mid of the year. There is no way of knowing whether they are effective or not. Pfizer and AstraZeneca are already on their way to developing the vaccines. But China somehow has let such dubious medication go unnoticed. 

According to the UN led Covax initiative, the vaccine will be disseminated in a phased manner, giving preference to medical aid workers, elderly, ailing patients and then the general population at large. But the paucity of doses worldwide has led a black market to thrive in China. 

Bribing your way through medical aid and services is a known practice in China. The trend has continued with vaccine doses too. Despite the fact that the vaccines have not received final regulatory approval, hundreds of thousands of people in China have been jabbed under the emergency-use program. That has heightened concern among scientists over potential safety risks.

China National Biotec Group Co., the arm of Sinopharm is still in the process of developing two leading Covid vaccines. They have widely tested the doses on more than 50,000 people in countries from Argentina to Egypt. But the company’s working has been seen as dubious. Sinopharm is known to have signed up with Canada for vaccine delivery but never kept it side of the deal and seemed to have diverted its doses to military personnel who were in the month of August stationed at the Indo-China border. 

According to the company, trials have been progressing smoothly, and it has not received any reports of serious adverse events in participants. Sinopharm was caught is cross firing between Canada and Chinese government, after which it withdrew shipment to Canada. 

UJM

Recent Posts

AI Adoption Accelerates Across Southeast Asia

AI adoption is accelerating across Southeast Asia as companies and governments invest in automation, data infrastructure, and digital skills to… Read More

January 6, 2026

International Feature Film Oscar Shortlist: 15 Films Advance as Nominations Near

The Academy’s International Feature Film Oscar shortlist is taking shape as 15 countries move forward to the next round of… Read More

January 6, 2026

Oil Prices Show Volatility as Global Demand Signals Remain Mixed

Oil prices volatility has returned as traders react to conflicting indicators on consumption, supply, and policy direction. Global demand signals… Read More

January 6, 2026

Asian Cinema’s Growing Influence on Global Audiences

Asian cinema influence has expanded rapidly as global audiences seek fresh storytelling, distinctive visual styles, and culturally grounded narratives. From… Read More

January 6, 2026

Global Economic Outlook: Recession Fears vs Recovery Signals

The global economic outlook in 2026 sits at a crossroads. On one side, recession fears persist due to sticky inflation… Read More

January 6, 2026

NATO Strengthens Eastern Flank Amid Rising Security Threats

NATO is also working faster to build up its eastern flank against the increasing security threats in border areas in… Read More

January 5, 2026

This website uses cookies.

Read More